The Role of Kappa-Opioid Receptors in Alcohol Use Disorders

Information

  • Research Project
  • 10241455
  • ApplicationId
    10241455
  • Core Project Number
    R01AA020394
  • Full Project Number
    5R01AA020394-11
  • Serial Number
    020394
  • FOA Number
    PA-18-484
  • Sub Project Id
  • Project Start Date
    9/1/2019 - 5 years ago
  • Project End Date
    8/31/2023 - a year ago
  • Program Officer Name
    EGLI, MARK
  • Budget Start Date
    9/1/2021 - 3 years ago
  • Budget End Date
    8/31/2022 - 2 years ago
  • Fiscal Year
    2021
  • Support Year
    11
  • Suffix
  • Award Notice Date
    8/23/2021 - 3 years ago

The Role of Kappa-Opioid Receptors in Alcohol Use Disorders

Project Summary. A fundamental characteristic of alcohol use disorders is the loss of control over alcohol consumption that results in progressively escalating levels of alcohol use and facilitates the progression to alcohol-dependence. Given the comorbidity of alcohol dependence and disorders of affect such as de-pression is extremely high, it has been posited that self-medication of negative affective states contributes to continued excessive alcohol use and relapse. Furthermore, negative affective states produced by chronic alcohol exposure can influence the neurocircuitry of cognitive control systems to perpetuate further excessive alcohol use. Once that degree of dysregulation is reached, components of the dependence cycle serve to facilitate each other in a manner that is extremely deleterious to personal, familial and societal welfare. The principal investigator?s long-term goal is to identify effective therapeutic targets and strategies for the treatment of AUDs. The objective of this renewal application, which is the next step in pursuit of that goal, is to understand the neuroadaptations in dynorphin (DYN) / kappa-opioid receptor (KOR) systems that occur in response to chronic alcohol exposure and contribute to maladaptive behavioral regulation in the form of maladaptive behavioral regulation. The central hypothesis is that the DYN / KOR system becomes progressively dysregulated in a manner that promotes the continued excessive consumption of alcohol and perpetuates the cycle of alcohol dependence. The rationale for the proposed studies is that identification of novel DYN / KOR- related treatment targets will enable the development of effective therapies designed to alleviate maladaptive behavioral regulation produced by dysphoria and alcohol dependence. This hypothesis will be tested by pursuing the following specific aims: Aim #1 evaluates kappa-opioid receptor dysregulation within cortical nuclei during acute withdrawal within working memory and impulse control domains. Aim #2 assesses the role of KORs in amygdalar nuclei in response to non-dependent dysphoria cues and alcohol-dependent withdrawal cue-induced maladaptive behavioral regulation using a combination of pharmacological and inducible genetic approaches. Animal models of self-administration, negative affective-like behavior, working memory and impulse control will serve as functional end-points to systematically investigate the mechanisms that contribute to maladaptive behavioral regulation in AUDs. These specific aims will collectively help to identify important neuroadaptations in DYN / KOR systems that can promote the transition to, and perpetuation of, AUDs and will provide much needed information regarding the influence of DYN / KORs on the neurocircuitry maladaptive behavioral regulation. Such a contribution is significant because it will help develop personalized therapeutic targets to treat AUDs that focus on the removal of maladaptive phenotypes; a strategy that should greatly increase medication compliance and decrease rates of relapse.

IC Name
NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM
  • Activity
    R01
  • Administering IC
    AA
  • Application Type
    5
  • Direct Cost Amount
    227180
  • Indirect Cost Amount
    112454
  • Total Cost
    339634
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    273
  • Ed Inst. Type
    SCHOOLS OF MEDICINE
  • Funding ICs
    NIAAA:339634\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    NAL
  • Study Section Name
    Neurotoxicology and Alcohol Study Section
  • Organization Name
    UNIVERSITY OF SOUTH FLORIDA
  • Organization Department
    PSYCHIATRY
  • Organization DUNS
    069687242
  • Organization City
    TAMPA
  • Organization State
    FL
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    336172008
  • Organization District
    UNITED STATES